328 related articles for article (PubMed ID: 16123334)
41. Activation of the farnesoid X receptor improves lipid metabolism in combined hyperlipidemic hamsters.
Bilz S; Samuel V; Morino K; Savage D; Choi CS; Shulman GI
Am J Physiol Endocrinol Metab; 2006 Apr; 290(4):E716-22. PubMed ID: 16291572
[TBL] [Abstract][Full Text] [Related]
42. HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LDL receptor, SR-B1, and ACAT in diet-induced syndrome X.
Roberts CK; Liang K; Barnard RJ; Kim CH; Vaziri ND
Kidney Int; 2004 Oct; 66(4):1503-11. PubMed ID: 15458444
[TBL] [Abstract][Full Text] [Related]
43. Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb/db mice with type 2 diabetes.
Wang Z; Jiang T; Li J; Proctor G; McManaman JL; Lucia S; Chua S; Levi M
Diabetes; 2005 Aug; 54(8):2328-35. PubMed ID: 16046298
[TBL] [Abstract][Full Text] [Related]
44. SREBP cleavage-activating protein (SCAP) is required for increased lipid synthesis in liver induced by cholesterol deprivation and insulin elevation.
Matsuda M; Korn BS; Hammer RE; Moon YA; Komuro R; Horton JD; Goldstein JL; Brown MS; Shimomura I
Genes Dev; 2001 May; 15(10):1206-16. PubMed ID: 11358865
[TBL] [Abstract][Full Text] [Related]
45. Keratinocyte growth factor and the transcription factors C/EBP alpha, C/EBP delta, and SREBP-1c regulate fatty acid synthesis in alveolar type II cells.
Mason RJ; Pan T; Edeen KE; Nielsen LD; Zhang F; Longphre M; Eckart MR; Neben S
J Clin Invest; 2003 Jul; 112(2):244-55. PubMed ID: 12865412
[TBL] [Abstract][Full Text] [Related]
46. Interaction between growth hormone and insulin in the regulation of lipoprotein metabolism in the rat.
Frick F; Lindén D; Améen C; Edén S; Mode A; Oscarsson J
Am J Physiol Endocrinol Metab; 2002 Nov; 283(5):E1023-31. PubMed ID: 12376331
[TBL] [Abstract][Full Text] [Related]
47. Increased hepatic lipogenesis but decreased expression of lipogenic gene in adipose tissue in human obesity.
Diraison F; Dusserre E; Vidal H; Sothier M; Beylot M
Am J Physiol Endocrinol Metab; 2002 Jan; 282(1):E46-51. PubMed ID: 11739082
[TBL] [Abstract][Full Text] [Related]
48. PPARgamma2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes.
Schadinger SE; Bucher NL; Schreiber BM; Farmer SR
Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1195-205. PubMed ID: 15644454
[TBL] [Abstract][Full Text] [Related]
49. Polyphenol-rich black chokeberry (Aronia melanocarpa) extract regulates the expression of genes critical for intestinal cholesterol flux in Caco-2 cells.
Kim B; Park Y; Wegner CJ; Bolling BW; Lee J
J Nutr Biochem; 2013 Sep; 24(9):1564-70. PubMed ID: 23517916
[TBL] [Abstract][Full Text] [Related]
50. Vascular and hepatic impact of short-term intermittent hypoxia in a mouse model of metabolic syndrome.
Trzepizur W; Gaceb A; Arnaud C; Ribuot C; Levy P; Martinez MC; Gagnadoux F; Andriantsitohaina R
PLoS One; 2015; 10(5):e0124637. PubMed ID: 25993257
[TBL] [Abstract][Full Text] [Related]
51. Obstructive sleep apnea and dyslipidemia: implications for atherosclerosis.
Drager LF; Jun J; Polotsky VY
Curr Opin Endocrinol Diabetes Obes; 2010 Apr; 17(2):161-5. PubMed ID: 20125003
[TBL] [Abstract][Full Text] [Related]
52. Decreased lipid synthesis in livers of mice with disrupted Site-1 protease gene.
Yang J; Goldstein JL; Hammer RE; Moon YA; Brown MS; Horton JD
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13607-12. PubMed ID: 11717426
[TBL] [Abstract][Full Text] [Related]
53. Tissue-specific effects of central leptin on the expression of genes involved in lipid metabolism in liver and white adipose tissue.
Gallardo N; Bonzón-Kulichenko E; Fernández-Agulló T; Moltó E; Gómez-Alonso S; Blanco P; Carrascosa JM; Ros M; Andrés A
Endocrinology; 2007 Dec; 148(12):5604-10. PubMed ID: 17823267
[TBL] [Abstract][Full Text] [Related]
54. Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice.
Memon RA; Tecott LH; Nonogaki K; Beigneux A; Moser AH; Grunfeld C; Feingold KR
Endocrinology; 2000 Nov; 141(11):4021-31. PubMed ID: 11089532
[TBL] [Abstract][Full Text] [Related]
55. Overexpression of Insig-1 in the livers of transgenic mice inhibits SREBP processing and reduces insulin-stimulated lipogenesis.
Engelking LJ; Kuriyama H; Hammer RE; Horton JD; Brown MS; Goldstein JL; Liang G
J Clin Invest; 2004 Apr; 113(8):1168-75. PubMed ID: 15085196
[TBL] [Abstract][Full Text] [Related]
56. Moderate consumption of beer reduces liver triglycerides and aortic cholesterol deposit in LDLr-/- apoB100/100 mice.
Degrace P; Moindrot B; Mohamed I; Gresti J; Clouet P
Atherosclerosis; 2006 Dec; 189(2):328-35. PubMed ID: 16487531
[TBL] [Abstract][Full Text] [Related]
57. Obesity and intermittent hypoxia increase tumor growth in a mouse model of sleep apnea.
Almendros I; Montserrat JM; Torres M; Bonsignore MR; Chimenti L; Navajas D; Farré R
Sleep Med; 2012 Dec; 13(10):1254-60. PubMed ID: 23149216
[TBL] [Abstract][Full Text] [Related]
58. Hypolipidemic action of the SERM acolbifene is associated with decreased liver MTP and increased SR-BI and LDL receptors.
Lemieux C; Gélinas Y; Lalonde J; Labrie F; Cianflone K; Deshaies Y
J Lipid Res; 2005 Jun; 46(6):1285-94. PubMed ID: 15741653
[TBL] [Abstract][Full Text] [Related]
59. Effect of adrenal medullectomy on metabolic responses to chronic intermittent hypoxia in the frequently sampled intravenous glucose tolerance test.
Shin MK; Han W; Joo H; Bevans-Fonti S; Shiota M; Stefanovski D; Polotsky VY
J Appl Physiol (1985); 2017 Apr; 122(4):767-774. PubMed ID: 28104753
[TBL] [Abstract][Full Text] [Related]
60. Intermittent hypoxia increases insulin resistance in genetically obese mice.
Polotsky VY; Li J; Punjabi NM; Rubin AE; Smith PL; Schwartz AR; O'Donnell CP
J Physiol; 2003 Oct; 552(Pt 1):253-64. PubMed ID: 12878760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]